Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-08-19
    E.g., 2018-08-19

Archive Search

1 results
12:00 AM, May 25, 2015  |  BioCentury | Strategy

You better you bet

genotypes. Blatt said J&J would start Phase II combination studies of ACH-3102 with Olysio and AL-335
and/or AL-516. AL-335 is a uridine-based nucleotide analog, which Blatt said has shown activity against all …